{{Rsnum
|rsid=7552722
|Chromosome=1
|position=115378734
|Orientation=plus
|GMAF=0.2709
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 30.1 | 54.9 | 15.0
| HCB | 54.7 | 40.9 | 4.4
| JPT | 46.4 | 42.9 | 10.7
| YRI | 74.7 | 24.7 | 0.7
| ASW | 64.9 | 33.3 | 1.8
| CHB | 54.7 | 40.9 | 4.4
| CHD | 51.4 | 43.1 | 5.5
| GIH | 69.0 | 27.0 | 4.0
| LWK | 85.5 | 13.6 | 0.9
| MEX | 74.1 | 22.4 | 3.4
| MKK | 71.0 | 27.1 | 1.9
| TSI | 51.0 | 39.2 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535911
  |Trait=Non-alcoholic fatty liver disease
  |Title=Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.
  |RiskAllele=A
  |Pval=7E-6
  |OR=1.27
  |ORtxt=[1.00-1.61]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}